Title: A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4-[3-isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl]-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease.
Journal: European journal of pharmacology 20120615
Title: Harada K, et al. A novel glycine transporter-1 (GlyT1) inhibitor, ASP2535 (4--isopropyl-5-(6-phenyl-3-pyridyl)-4H-1,2,4-triazol-4-yl-2,1,3-benzoxadiazole), improves cognition in animal models of cognitive impairment in schizophrenia and Alzheimer's disease. Eur J Pharmacol. 2012 Jun 15;685(1-3):59-69.